Zura bio enters into sponsored research agreement with benaroya research institute

Henderson, nev.--(business wire)---- $zura #teamzura--zura bio limited (nasdaq: zura) (“zura bio”), a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, and benaroya research institute (bri), a seattle based non-profit research institute within virginia mason franciscan health, announced that they have entered into a sponsored research agreement focused on further characterizing the pivotal role of interleukin-7 receptor alpha (il-7rΑ) in t.
ZURA Ratings Summary
ZURA Quant Ranking